Why do more than 80% of the world’s tobacco-related deaths and chronic diseases occur in low- and middle-income countries?
Why do most deaths attributable to second-hand tobacco smoke occur among children & women?
Why are tobacco’s harmful effects concentrated among groups who are the most vulnerable?
TReND publishes Research to Reduce Global Tobacco Inequalities, a special supplement to Cancer Causes and Control, in March 2012. Read more…
While prior research has documented disparities in smoking and lung cancer mortality rates by SES and race/ethnicity in the U.S., whether smoking or related mortality differ by SES within racial/ethnic groups has not been extensively studied. This study investigated a range of outcomes from tobacco use, looking at socioeconomic gradients separately among the three largest racial/ethnic groups in the U.S.—non-Hispanic blacks, Hispanics/Latinos, and non-Hispanic whites.
The US Food and Drug Administration released its action plan for enforcing restrictions on tobacco advertising and promotion in October 2010. “Enforcement Action Plan for Promotion and Advertising Restrictions” was developed in consultation with public health organizations and other groups representing populations most affected by the tobacco industry’s marketing—young people and minority communities.
The FDA’s strategy to enforce federal regulations designed to reduce the appeal of tobacco products and restrict access to cigarettes and smokeless tobacco by people under the age of 18 includes marketing surveillance, retailer compliance inspections, enforcement tools, and education to encourage voluntary compliance.